BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 28416122)

  • 21. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas.
    Tanaka M; Chari S; Adsay V; Fernandez-del Castillo C; Falconi M; Shimizu M; Yamaguchi K; Yamao K; Matsuno S;
    Pancreatology; 2006; 6(1-2):17-32. PubMed ID: 16327281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low progression of intraductal papillary mucinous neoplasms with worrisome features and high-risk stigmata undergoing non-operative management: a mid-term follow-up analysis.
    Crippa S; Bassi C; Salvia R; Malleo G; Marchegiani G; Rebours V; Levy P; Partelli S; Suleiman SL; Banks PA; Ahmed N; Chari ST; Fernández-Del Castillo C; Falconi M
    Gut; 2017 Mar; 66(3):495-506. PubMed ID: 26743012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential diagnosis of cystic tumors of the pancreas by endoscopic ultrasonography.
    Kubo H; Nakamura K; Itaba S; Yoshinaga S; Kinukawa N; Sadamoto Y; Ito T; Yonemasu H; Takayanagi R
    Endoscopy; 2009 Aug; 41(8):684-9. PubMed ID: 19670136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inferior head resection of the pancreas for intraductal papillary mucinous neoplasms.
    Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kobayashi S; Kojima M; Miyauchi H; Asano T
    J Hepatobiliary Pancreat Sci; 2010 Nov; 17(6):798-802. PubMed ID: 19727540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histopathological evaluation of resected intraductal papillary mucinous neoplasms reveals distinct patterns of invasion in associated carcinomas.
    Rift CV; Lund EL; Scheie D; Hansen CP; Hasselby JP
    Hum Pathol; 2021 Jul; 113():47-58. PubMed ID: 33915115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraductal papillary mucinous neoplasms of the pancreas: an increasingly recognized clinicopathologic entity.
    Sohn TA; Yeo CJ; Cameron JL; Iacobuzio-Donahue CA; Hruban RH; Lillemoe KD
    Ann Surg; 2001 Sep; 234(3):313-21; discussion 321-2. PubMed ID: 11524584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proper management and follow-up strategy of branch duct intraductal papillary mucinous neoplasms of the pancreas.
    Bae SY; Lee KT; Lee JH; Lee JK; Lee KH; Rhee JC
    Dig Liver Dis; 2012 Mar; 44(3):257-60. PubMed ID: 22030480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical Characteristics of Patients With Surgically Resected Pancreatic Cysts: A Retrospective Analysis of 136 Patients.
    Gong TT; Wang W
    J Ultrasound Med; 2023 Apr; 42(4):901-913. PubMed ID: 36029231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathologic T1 and T2 encapsulated invasive carcinomas arising from mucinous cystic neoplasms of the pancreas have favorable prognosis and might be treated conservatively.
    Liang H; Xie W; Lin X; Wang T; Xie J; Wang C; Xiao SY; Guo Y
    J Pathol Clin Res; 2021 Sep; 7(5):507-516. PubMed ID: 34062050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison between intraductal papillary neoplasms of the biliary tract (BT-IPMNs) and intraductal papillary mucinous neoplasms of the pancreas (P-IPMNs) reveals distinct clinical manifestations and outcomes.
    Minagawa N; Sato N; Mori Y; Tamura T; Higure A; Yamaguchi K
    Eur J Surg Oncol; 2013 Jun; 39(6):554-8. PubMed ID: 23506840
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgical outcomes of noninvasive and minimally invasive intraductal papillary-mucinous neoplasms of the pancreas.
    Takahashi H; Nakamori S; Nakahira S; Tsujie M; Takahshi Y; Marubashi S; Miyamoto A; Takeda Y; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
    Ann Surg Oncol; 2006 Jul; 13(7):955-60. PubMed ID: 16788757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intraductal papillary mucinous neoplasm (IPMN) with high-grade dysplasia is a risk factor for the subsequent development of pancreatic ductal adenocarcinoma.
    Rezaee N; Barbon C; Zaki A; He J; Salman B; Hruban RH; Cameron JL; Herman JM; Ahuja N; Lennon AM; Weiss MJ; Wood LD; Wolfgang CL
    HPB (Oxford); 2016 Mar; 18(3):236-46. PubMed ID: 27017163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystic neoplasia of the pancreas: pathology and biology.
    Adsay NV
    J Gastrointest Surg; 2008 Mar; 12(3):401-4. PubMed ID: 17957438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Malignancy risk factors and prognostic variables of pancreatic mucinous cystic neoplasms in Chinese patients.
    Xia Q; Li F; Min R; Sun S; Han YX; Feng ZZ; Li N
    World J Gastroenterol; 2023 May; 29(20):3119-3132. PubMed ID: 37346158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer.
    Reddy RP; Smyrk TC; Zapiach M; Levy MJ; Pearson RK; Clain JE; Farnell MB; Sarr MG; Chari ST
    Clin Gastroenterol Hepatol; 2004 Nov; 2(11):1026-31. PubMed ID: 15551256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of limited resection for patients with intraductal papillary mucinous neoplasm of the pancreas: A single-center experience.
    Asano T; Nakamura T; Noji T; Okamura K; Tsuchikawa T; Ebihara Y; Nakanishi Y; Tanaka K; Matsui A; Shichinohe T; Hirano S
    Pancreatology; 2020 Oct; 20(7):1399-1405. PubMed ID: 32972836
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lymphoepithelial cyst of the pancreas: can common imaging features help to avoid resection?
    Khristenko E; Garcia EE; Gaida MM; Hackert T; Mayer P; Kauczor HU; Klauss M
    Langenbecks Arch Surg; 2023 Feb; 408(1):82. PubMed ID: 36773118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.
    Chari ST; Yadav D; Smyrk TC; DiMagno EP; Miller LJ; Raimondo M; Clain JE; Norton IA; Pearson RK; Petersen BT; Wiersema MJ; Farnell MB; Sarr MG
    Gastroenterology; 2002 Nov; 123(5):1500-7. PubMed ID: 12404225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic serous oligocystic adenomas: clinicopathologic features and a comparison with serous microcystic adenomas and mucinous cystic neoplasms.
    Goh BK; Tan YM; Yap WM; Cheow PC; Chow PK; Chung YF; Wong WK; Ooi LL
    World J Surg; 2006 Aug; 30(8):1553-9. PubMed ID: 16773248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AKR1B10 expression by immunohistochemistry in surgical resections and fine needle aspiration cytology material in patients with cystic pancreatic lesions; potential for improved nonoperative diagnosis.
    Connor JP; Esbona K; Matkowskyj KA
    Hum Pathol; 2017 Dec; 70():77-83. PubMed ID: 29079172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.